The global drug formulation market is set for remarkable growth, with total sales projected to increase from USD 1.7 ...

Ultrafine Mist: Our rechargeable nebulizer uses advanced ultrasonic mesh technology to transform liquids into fine mist particles. Two Adjustable Modes: Featuring two modes, the Strong Mode ...

2-Year U.S. Treasury Note Continuous Contract $103.289-0.031-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.586-0.102-0.09% 10-Year U.S. Treasury Note Continuous Contract $109.906-0.172 ...

Multi-media patient education support materials and built-in conveniences make this efficient nebulizer system the ideal choice for encouraging adherence to aerosol medication treatment plans.

2-Year U.S. Treasury Note Continuous Contract $103.313 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $107.672 0.133 0.12% 10-Year U.S. Treasury Note Continuous Contract $110.063 0.234 ...

Having power at home can be essential for treating respiratory illnesses, he said. For example, nebulizers that deliver essential medicine require power to operate. If patients don’t have power ...

Continuous manufacturing could be the solution. Unlike batch manufacturing, where drug production is segmented into a series of slow-moving steps, continuous manufacturing relies on a fully ...

The limited amount of research devoted to the nebulization of the drugs listed above and the lack of definitive preparation guidelines presented in the research can lead to confusion in deciding ...

Am J Health Syst Pharm. 2006;63(18):1704-1716. The nebulized form of colistin appears to limit systemic toxicity and if the risk of bronchospasm is overcome by the benefit of colistin therapy ...

Continuous platform development Our commitment to ongoing innovation ensures our technological platform is continuously improved - and always equipped to satisfy the most demanding users.

Now, Vyalev (foscarbidopa and foslevodopa) has become the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's ...